Precipio ROA 2010-2025 | PRPO

Current and historical return on assets (ROA) values for Precipio (PRPO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Precipio ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.00B $0.02B -17.39%
2024-12-31 $0.00B $0.02B -23.53%
2024-09-30 $0.00B $0.02B -17.39%
2024-06-30 $0.00B $0.02B -16.90%
2024-03-31 $0.00B $0.02B -21.92%
2023-12-31 $-0.01B $0.02B -26.67%
2023-09-30 $-0.01B $0.02B -40.51%
2023-06-30 $-0.01B $0.02B -47.62%
2023-03-31 $-0.01B $0.02B -43.96%
2022-12-31 $-0.01B $0.02B -48.00%
2022-09-30 $-0.01B $0.02B -44.44%
2022-06-30 $-0.01B $0.03B -37.93%
2022-03-31 $-0.01B $0.03B -38.71%
2021-12-31 $-0.01B $0.03B -27.59%
2021-09-30 $-0.01B $0.03B -29.91%
2021-06-30 $-0.01B $0.03B -37.50%
2021-03-31 $-0.01B $0.02B -39.51%
2020-12-31 $-0.01B $0.02B -70.00%
2020-09-30 $-0.02B $0.02B -81.01%
2020-06-30 $-0.02B $0.02B -74.07%
2020-03-31 $-0.02B $0.02B -90.48%
2019-12-31 $-0.01B $0.02B -64.37%
2019-09-30 $-0.02B $0.02B -76.40%
2019-06-30 $-0.02B $0.02B -83.52%
2019-03-31 $-0.02B $0.02B -67.37%
2018-12-31 $-0.02B $0.02B -80.81%
2018-09-30 $-0.03B $0.03B -100.00%
2018-06-30 $-0.03B $0.03B -112.28%
2018-03-31 $-0.04B $0.03B -121.60%
2017-12-31 $-0.03B $0.03B -132.00%
2017-09-30 $-0.02B $0.04B -102.70%
2017-06-30 $-0.01B $0.04B -87.80%
2017-03-31 $0.00B $0.00B 0.00%
2016-12-31 $0.00B $0.00B -120.00%
2016-09-30 $-0.02B $0.00B -685.71%
2016-06-30 $-0.03B $0.00B -355.56%
2016-03-31 $-0.04B $0.00B -218.75%
2015-12-31 $-0.03B $0.01B -144.68%
2015-09-30 $-0.02B $0.02B -67.23%
2015-06-30 $-0.01B $0.03B -38.10%
2015-03-31 $-0.01B $0.03B -41.27%
2014-12-31 $-0.01B $0.03B -45.53%
2014-09-30 $-0.01B $0.03B -39.02%
2014-06-30 $-0.02B $0.03B -57.60%
2014-03-31 $-0.02B $0.03B -51.13%
2013-12-31 $-0.02B $0.03B -47.55%
2013-09-30 $-0.02B $0.03B -39.47%
2013-06-30 $-0.01B $0.04B -29.63%
2013-03-31 $-0.01B $0.04B -23.81%
2012-12-31 $-0.01B $0.04B -20.69%
2012-09-30 $-0.01B $0.04B -16.57%
2012-06-30 $-0.01B $0.05B -15.38%
2012-03-31 $-0.01B $0.05B -30.99%
2011-12-31 $-0.01B $0.03B -34.92%
2011-09-30 $-0.01B $0.03B -38.71%
2011-06-30 $-0.01B $0.03B -40.74%
2011-03-31 $-0.01B $0.03B -26.37%
2010-12-31 $0.00B $0.03B -15.79%
2010-09-30 $0.00B $0.01B -13.33%
2010-06-30 $0.00B $0.01B -6.56%
2010-03-31 $0.00B $0.02B -6.35%
2009-12-31 $0.00B $0.02B -12.50%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.021B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.919B 58.42
Doximity (DOCS) United States $11.431B 52.92
Hims & Hers Health (HIMS) United States $10.838B 112.61
Tempus AI (TEM) United States $10.042B 0.00
IRhythm Technologies (IRTC) United States $4.445B 0.00
Inspire Medical Systems (INSP) United States $3.743B 58.48
Hinge Health (HNGE) United States $3.360B 0.00
Privia Health (PRVA) United States $2.603B 177.92
Enovis (ENOV) United States $1.886B 10.52
Phreesia (PHR) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.514B 0.00
Clover Health Investments (CLOV) United States $1.471B 0.00
10x Genomics (TXG) United States $1.468B 0.00
Azenta (AZTA) United States $1.439B 66.87
Evolent Health (EVH) United States $1.367B 116.40
Omnicell (OMCL) United States $1.355B 23.90
Claritev (CTEV) United States $0.794B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.486B 0.00
Butterfly Network (BFLY) United States $0.465B 0.00
Talkspace (TALK) United States $0.443B 132.50
Outset Medical (OM) United States $0.362B 0.00
TruBridge (TBRG) United States $0.340B 754.67
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.268B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.217B 0.00
KORU Medical Systems (KRMD) United States $0.169B 0.00
American Well (AMWL) United States $0.127B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
Pulmonx (LUNG) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.100B 3.81
Insight Molecular Diagnostics (IMDX) United States $0.087B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.075B 0.00
111 (YI) China $0.065B 0.00
Zepp Health (ZEPP) Netherlands $0.050B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00